Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

BACKGROUND: Effective antiplatelet therapy is critical for patients with ST-segment elevation myocardial infarction (STEMI) and receiving primary percutaneous coronary interventions (PPCI). Intracoronary (IC) and intravenous (IV) administration of tirofiban are commonly used during the procedure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Rui, Liu, Rugang, Zhang, Jiajun, Li, Yong, Wei, Shujian, Xu, Feng, Li, Xiaoxing, Li, Chuanbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172923/
https://www.ncbi.nlm.nih.gov/pubmed/37180928
http://dx.doi.org/10.1016/j.heliyon.2023.e15842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172923/
https://www.ncbi.nlm.nih.gov/pubmed/37180928
http://dx.doi.org/10.1016/j.heliyon.2023.e15842

Ejemplares similares